{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:41:17Z","timestamp":1791859277025,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":1271,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2 TR002379"],"award-info":[{"award-number":["KL2 TR002379"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1111\/ajt.15175","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T12:41:03Z","timestamp":1541767263000},"page":"1671-1683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Long-term outcomes of eculizumab-treated positive crossmatch recipients: Allograft survival, histologic findings, and natural history of the donor-specific antibodies"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3274-3277","authenticated-orcid":false,"given":"Carrie A.","family":"Schinstock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8495-9782","authenticated-orcid":false,"given":"Andrew J.","family":"Bentall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9318-2437","authenticated-orcid":false,"given":"Byron H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn D.","family":"Cornell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7392-5483","authenticated-orcid":false,"given":"Matthew","family":"Everly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6921-6123","authenticated-orcid":false,"given":"Manish J.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Stegall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1111\/ajt.15175_bib1","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/ajt.13770","article-title":"Changes in deceased donor kidney transplantation one year after KAS implementation","volume":"16","author":"Stewart","year":"2016","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15175_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.humimm.2016.10.010","article-title":"The new kidney allocation system does not equally advantage all very high cPRA candidates - A single center analysis","volume":"78","author":"Hahn","year":"2017","journal-title":"Hum Immunol."},{"issue":"3","key":"10.1111\/ajt.15175_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.07720715","article-title":"Allocating deceased donor kidneys to candidates with high panel-reactive antibodies","volume":"11","author":"Gebel","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"10.1111\/ajt.15175_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1111\/ajt.15175_bib5","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJMoa1508380","article-title":"Survival benefit with kidney transplants from HLA-incompatible live donors","volume":"374","author":"Orandi","year":"2016","journal-title":"N Engl J Med."},{"issue":"3","key":"10.1111\/ajt.15175_bib6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2009.02985.x","article-title":"Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation","volume":"10","author":"Gloor","year":"2010","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15175_bib7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1600-6143.2006.01709.x","article-title":"The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection","volume":"7","author":"Locke","year":"2007","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15175_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.tp.0000243739.31440.2b","article-title":"Successful rescue of refractory, severe antibody mediated rejection with splenectomy","volume":"83","author":"Kaplan","year":"2007","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.15175_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2012.04291.x","article-title":"Five-year outcomes in living donor kidney transplants with a positive crossmatch","volume":"13","author":"Bentall","year":"2013","journal-title":"Am J Transplant."},{"issue":"9","key":"10.1111\/ajt.15175_bib10","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/j.1600-6143.2007.01895.x","article-title":"Transplant glomerulopathy: subclinical incidence and association with alloantibody","volume":"7","author":"Gloor","year":"2007","journal-title":"Am J Transplant."},{"issue":"3","key":"10.1111\/ajt.15175_bib11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/TP.0000000000000064","article-title":"Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients","volume":"98","author":"Vo","year":"2014","journal-title":"Transplantation."},{"issue":"12","key":"10.1111\/ajt.15175_bib12","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1681\/ASN.2012070664","article-title":"Donor-specific antibodies adversely affect kidney allograft outcomes","volume":"23","author":"Mohan","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"10.1111\/ajt.15175_bib13","first-page":"1","article-title":"Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation","volume":"162","author":"Lefaucheur","year":"2009","journal-title":"Contrib Nephrol."},{"issue":"8","key":"10.1111\/ajt.15175_bib14","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol."},{"issue":"11","key":"10.1111\/ajt.15175_bib15","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.15175_bib16","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1681\/ASN.2017050589","article-title":"Complement-activating anti-HLA antibodies in kidney transplantation: allograft gene expression profiling and response to treatment","volume":"29","author":"Lefaucheur","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"10.1111\/ajt.15175_bib17","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ajt.13168","article-title":"Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year","volume":"15","author":"Cornell","year":"2015","journal-title":"Am J Transplant."},{"issue":"12","key":"10.1111\/ajt.15175_bib18","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1111\/j.1600-6143.2008.02441.x","article-title":"Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation","volume":"8","author":"Burns","year":"2008","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15175_bib19","first-page":"293","article-title":"Risk stratification of human leukocyte antigen class II donor specific antibody positive patients by immunoglobulin G subclasses","volume":"31","author":"Taniguchi","year":"2015","journal-title":"Clin Transpl."},{"issue":"4","key":"10.1111\/ajt.15175_bib20","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1600-6143.2010.03312.x","article-title":"The histology of solitary renal allografts at 1 and 5 years after transplantation","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant."},{"issue":"10","key":"10.1111\/ajt.15175_bib21","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/TP.0000000000000188","article-title":"Differences in chronic intragraft inflammation between positive crossmatch and ABO-incompatible kidney transplantation","volume":"98","author":"Bentall","year":"2014","journal-title":"Transplantation."},{"issue":"2","key":"10.1111\/ajt.15175_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant."},{"issue":"6","key":"10.1111\/ajt.15175_bib23","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/TP.0b013e31819a6788","article-title":"Rises and falls in donor-specific and third-party HLA antibody levels after antibody incompatible transplantation","volume":"87","author":"Higgins","year":"2009","journal-title":"Transplantation."},{"issue":"10","key":"10.1111\/ajt.15175_bib24","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1097\/TP.0000000000001650","article-title":"Long-term outcomes of kidney transplantation in patients with high levels of preformed DSA: the Necker high-risk transplant program","volume":"101","author":"Amrouche","year":"2017","journal-title":"Transplantation."},{"issue":"10","key":"10.1111\/ajt.15175_bib25","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1097\/TP.0000000000001619","article-title":"Kidney transplant with low levels of DSA or low positive B-flow crossmatch: an underappreciated option for highly sensitized transplant candidates","volume":"101","author":"Schinstock","year":"2017","journal-title":"Transplantation."},{"issue":"7","key":"10.1111\/ajt.15175_bib26","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/ajt.12786","article-title":"Quantifying the risk of incompatible kidney transplantation: a multicenter study","volume":"14","author":"Orandi","year":"2014","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15175_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2014111120","article-title":"IgG donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury","volume":"27","author":"Lefaucheur","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"10.1111\/ajt.15175_bib28","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2016030368","article-title":"Value of donor-specific anti-HLA antibody monitoring and characterization for risk stratification of kidney allograft loss","volume":"28","author":"Viglietti","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"12","key":"10.1111\/ajt.15175_bib29","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1056\/NEJMra1802677","article-title":"Antibody-mediated rejection of solid-organ allografts","volume":"379","author":"Loupy","year":"2018","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1111\/ajt.15175_bib30","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.kint.2018.03.015","article-title":"Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection","volume":"94","author":"Viglietti","year":"2018","journal-title":"Kidney Int."},{"issue":"13","key":"10.1111\/ajt.15175_bib31","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1111\/ajt.15175_bib32","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/TP.0000000000000511","article-title":"Characteristics of circulating donor human leukocyte antigen-specific immunoglobulin G antibodies predictive of acute antibody-mediated rejection and kidney allograft failure","volume":"99","author":"Kannabhiran","year":"2015","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15175_bib33","first-page":"700","article-title":"Kidney transplant with low level DSA and low positive B-flow crossmatch: an underappreciated option for highly sensitized transplant candidates","volume":"16","author":"Schinstock","year":"2016","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15175_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.trim.2013.05.001","article-title":"Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death","volume":"28","author":"Fidler","year":"2013","journal-title":"Transpl Immunol."},{"issue":"10070","key":"10.1111\/ajt.15175_bib35","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(16)31595-1","article-title":"Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis","volume":"389","author":"Manook","year":"2017","journal-title":"Lancet."},{"issue":"12","key":"10.1111\/ajt.15175_bib36","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/tri.12648","article-title":"Subclass analysis of donor HLA-specific IgG in antibody-incompatible renal transplantation reveals a significant association of IgG4 with rejection and graft failure","volume":"28","author":"Khovanova","year":"2015","journal-title":"Transpl Int."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15175","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15175","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15175","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522091122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522091122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:24:26Z","timestamp":1761629066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522091122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1600613522091122"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15175","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes of eculizumab-treated positive crossmatch recipients: Allograft survival, histologic findings, and natural history of the donor-specific antibodies","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}